HIV, cholesterol-lowering and cancer medicines dominate price disclosure reductions for April 2020 with almost thirty medicines across over 60 dosages and manners of administration taking an average cut of just over 20 per cent. …
Latest Video
New Stories
-
Alterity secures option underwriting as it prepares for pivotal MSA trial
August 31, 2026 - - Australian Biotech -
Avecho resumes pivotal insomnia trial recruitment after positive interim review
August 31, 2026 - - Australian Biotech -
Expansion opens PBS access for more with advanced cancer, but it took a long time
August 31, 2026 - - Latest News -
A decade is more than enough - the case for term limits on advisory committees
August 31, 2026 - - Latest News -
September agenda puts cancer drugs, RSV prevention and ADHD access in focus
August 31, 2026 - - Latest News -
Funding brings a new targeted treatment for Australians with lupus kidney disease
August 31, 2026 - - Latest News -
Astellas Australia turns to rare disease leader Guillaume Pfeiffer for next chapter
August 31, 2026 -